CLINICAL SYMPTOMS AND REGIONAL CEREBRAL BLOOD-FLOW IN SCHIZOPHRENIA

被引:40
作者
YUASA, S [1 ]
KURACHI, M [1 ]
SUZUKI, M [1 ]
KADONO, Y [1 ]
MATSUI, M [1 ]
SAITOH, O [1 ]
SETO, H [1 ]
机构
[1] TOYAMA MED & PHARMACEUT UNIV,DEPT RADIOL,TOYAMA 93001,JAPAN
关键词
SPECT; REGIONAL CEREBRAL BLOOD FLOW; CLINICAL SYMPTOMS; STEPWISE MULTIPLE REGRESSION; SCHIZOPHRENIA;
D O I
10.1007/BF02191809
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study examined the relationship between clinical symptoms and regional cerebral blood flow (rCBF) in schizophrenic patients using single photon emission computed tomography (SPECT). The subjects were 26 medicated schizophrenic patients diagnosed according to DSM-LU-R criteria. Clinical symptoms were assessed using the Scale for the Assessment of Negative Symptoms (SANS), selected items for the Positive and Negative Syndrome Scale (PANSS), and the scale for Schneider's first rank symptoms. Resting rCBF was measured using N-isopropyl-p-[I-123] iodoamphetamine (I-123 IMP) SPECT, and relative rCBF distribution was evaluated in nine regions of interest in each hemisphere. Factor analysis of symptom ratings indicated four separate syndromes: psychomotor poverty, alienation (hallucination and disturbance of the self), delusion, and disorganization. Stepwise multiple regression analysis showed the psychomotor poverty syndrome to be correlated with decreased rCBF in bilateral superior frontal areas and increased rCBF in the left thalamus and right basal ganglia. The disorganization syndrome was correlated with increased rCBF in bilateral anterior cingulates and decreased rCBF in bilateral middle frontal areas. The alienation syndrome was shown related to increased rCBF in the right inferior frontal area and parietal area. Dysfunction in distinctive neural networks involving various prefrontal areas would thus appear to underlie these syndromes in schizophrenia.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 37 条
[1]   THALAMIC ABNORMALITIES IN SCHIZOPHRENIA VISUALIZED THROUGH MAGNETIC-RESONANCE IMAGE AVERAGING [J].
ANDREASEN, NC ;
ARNDT, S ;
SWAYZE, V ;
CIZADLO, T ;
FLAUM, M ;
OLEARY, D ;
EHRHARDT, JC ;
YUH, WTC .
SCIENCE, 1994, 266 (5183) :294-298
[2]  
ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P943
[3]  
[Anonymous], 1984, SCALE ASSESSMENT POS
[4]   THE DISTINCTION OF POSITIVE AND NEGATIVE SYMPTOMS - THE FAILURE OF A 2-DIMENSIONAL MODEL [J].
ARNDT, S ;
ALLIGER, RJ ;
ANDREASEN, NC .
BRITISH JOURNAL OF PSYCHIATRY, 1991, 158 :317-322
[5]  
BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996
[6]   GLUCOSE METABOLIC-RATE IN NORMALS AND SCHIZOPHRENICS DURING THE CONTINUOUS PERFORMANCE-TEST ASSESSED BY POSITRON EMISSION TOMOGRAPHY [J].
BUCHSBAUM, MS ;
NUECHTERLEIN, KH ;
HAIER, RJ ;
WU, J ;
SICOTTE, N ;
HAZLETT, E ;
ASARNOW, R ;
POTKIN, S ;
GUICH, S .
BRITISH JOURNAL OF PSYCHIATRY, 1990, 156 :216-227
[7]   THE CURRENT STATUS OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA [J].
CARLSSON, A .
NEUROPSYCHOPHARMACOLOGY, 1988, 1 (03) :179-186
[8]  
Crow T J, 1979, Ciba Found Symp, P335
[9]   THE 2-SYNDROME CONCEPT - ORIGINS AND CURRENT STATUS [J].
CROW, TJ .
SCHIZOPHRENIA BULLETIN, 1985, 11 (03) :471-486
[10]   MOLECULAR PATHOLOGY OF SCHIZOPHRENIA - MORE THAN ONE DISEASE PROCESS [J].
CROW, TJ .
BRITISH MEDICAL JOURNAL, 1980, 280 (6207) :66-68